相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Inhibitory Effects of N-[2-(4-acetyl-1-piperazinyl) phenyl]-2-(2-chlorophenoxy) acetamide on Osteoclast Differentiation In Vitro via the Downregulation of TRAF6
Zhihao Chen et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Madecassoside inhibits estrogen deficiency-induced osteoporosis by suppressing RANKL-induced osteoclastogenesis
Qingqing Wang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)
Pseurotin A Inhibits Osteoclastogenesis and Prevents Ovariectomized-Induced Bone Loss by Suppressing Reactive Oxygen Species
Kai Chen et al.
THERANOSTICS (2019)
STAC2 negatively regulates osteoclast formation by targeting the RANK signaling complex
Eutteum Jeong et al.
CELL DEATH AND DIFFERENTIATION (2018)
Artemether attenuates LPS-induced inflammatory bone loss by inhibiting osteoclastogenesis and bone resorption via suppression of MAPK signaling pathway
Haobo Wu et al.
CELL DEATH & DISEASE (2018)
Regulation of Osteoclast Differentiation by Cytokine Networks
Dulshara Sachini Amarasekara et al.
IMMUNE NETWORK (2018)
Inhibitory Effects of 2N1HIA (2-(3-(2-Fluoro-4-Methoxyphenyl)-6-Oxo-1(6H)-Pyridazinyl)-N-1H-Indol-5-Ylacetamide) on Osteoclast Differentiation via Suppressing Cathepsin K Expression
Sun-Hee Ahn et al.
MOLECULES (2018)
Matrine prevents bone loss in ovariectomized mice by inhibiting RANKL-induced osteoclastogenesis
Xiao Chen et al.
FASEB JOURNAL (2017)
Selective Regulation of MAPK Signaling Mediates RANKL-dependent Osteoclast Differentiation
Kyunghee Lee et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2016)
TGF-β/BMP signaling and other molecular events: regulation of osteoblastogenesis and bone formation
Md Shaifur Rahman et al.
BONE RESEARCH (2015)
NF-κB-Mediated Regulation of Osteoclastogenesis
Brendan F. Boyce et al.
ENDOCRINOLOGY AND METABOLISM (2015)
Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand-induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+-nuclear factor of activated T-cells cytoplasmic 1 signaling pathways
Xian Wu et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2012)
Disorders of Bone Remodeling
Xu Feng et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 6 (2011)
Maslinic Acid Suppresses Osteoclastogenesis and Prevents Ovariectomy-Induced Bone Loss by Regulating RANKL-Mediated NF-κB and MAPK Signaling Pathways
Chenghai Li et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
Negative Feedback Control of Osteoclast Formation through Ubiquitin-mediated Down-regulation of NFATc1
Jung Ha Kim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Osteoporosis treatments and adverse events
Daniel H. Solomon et al.
CURRENT OPINION IN RHEUMATOLOGY (2009)
Bisphosphonate-associated adverse events
Peter D. Papapetrou
HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM (2009)
Increasing Options for the Treatment of Osteoporosis
Sundeep Khosla
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Water solution of onion crude powder inhibits RANKL-induced osteoclastogenesis through ERK, p38 and NF-kappa B pathways
C. -H. Tang et al.
OSTEOPOROSIS INTERNATIONAL (2009)
Normal Bone Anatomy and Physiology
Bart Clarke
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Receptor activator of nuclear factor kappa B ligand and osteoprotegerin regulation of bone remodeling in health and disease
Ann E. Kearns et al.
ENDOCRINE REVIEWS (2008)
NFATc1 in mice represses osteoprotegerin during osteoclastogenesis and dissociates systemic osteopenia from inflammation in cherubism
Antonios O. Aliprantis et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Bisphosphonates: Mechanism of action and role in clinical practice
Mathew T. Drake et al.
MAYO CLINIC PROCEEDINGS (2008)
TRAF6 Autoubiquitination-Independent Activation of the NFκB and MAPK Pathways in Response to IL-1 and RANKL
Matthew C. Walsh et al.
PLOS ONE (2008)
TRAF6 ubiquitin ligase is essential for RANKL signaling and osteoclast differentiation
Betty Lamothe et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Ubiquitin-mediated activation of TAK1 and IKK
A. Adhikari et al.
ONCOGENE (2007)
Site-specific Lys-63-linked tumor necrosis factor receptor-associated factor 6 auto-ubiquitination is a critical determinant of IκB kinase activation
Betty Lamothe et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
The molecular understanding of osteoclast differentiation
Masataka Asagiri et al.
BONE (2007)
Biology of RANK, RANKL, and osteoprotegerin
Brendan F. Boyce et al.
ARTHRITIS RESEARCH & THERAPY (2007)
Calcineurin/NFAT signaling in osteoblasts regulates bone mass
Monte M. Winslow et al.
DEVELOPMENTAL CELL (2006)
Roles for NF-kappa B and c-Fos in osteoclasts
BF Boyce et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2005)
The role of cathepsin K in normal bone resorption
BR Troen
DRUG NEWS & PERSPECTIVES (2004)
Matrix metalloproteinases (MMP) and cathepsin K contribute differently to osteoclastic activities
JM Delaissé et al.
MICROSCOPY RESEARCH AND TECHNIQUE (2003)
Osteoclast differentiation and activation
WJ Boyle et al.
NATURE (2003)
TRAF6, a molecular bridge spanning adaptive immunity, innate immunity and osteoimmunology
H Wu et al.
BIOESSAYS (2003)
Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts
H Takayanagi et al.
DEVELOPMENTAL CELL (2002)
Segregation of TRAF6-mediated signaling pathways clarifies its role in osteoclastogenesis
N Kobayashi et al.
EMBO JOURNAL (2001)
分享论文
